Brainsway Ltd. American Depositary Shares (BWAY) Stock Price

BWAYStock
$11.44+153.31%52W
Market Cap$460.49M
P/E61.33x
PEG Ratio—
Div yield—
Beta0.96

BWAY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-24.78%
Price vs S&P 500 (4W)-7.46%
VGM Score56.89
P/E Ratio (Annual)61.33x

BWAY Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$0.07$0.07-4.54%(-$0.00)
Q1 2026$0.05$0.06+20.00%(+$0.01)
Q4 2025$0.03$0.06+155.36%(+$0.04)
Q3 2025$0.02$0.02-14.27%(-$0.00)
Q2 2025$0.02$0.03+53.85%(+$0.01)

BWAY Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.29
4.29
4.29
4.29

Industry Peers — Surgical & Medical Instruments(142)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
BWAYBrainsway Ltd. American Depositary Shares
DBB9.5x12.2%74.9%5.8%$11.44
SYKStryker CorporationCBC4.4x11.8%65.3%21.3%$294.66
MMM3M CompanyCDB3.4x-5.0%39.4%18.4%$164.75
BSXBoston Scientific Corp.CBC3.1x15.2%69.5%19.8%$44.39
BDXBecton, Dickinson and Co.BDA2.5x6.3%46.7%9.6%$191.75
MDLNMedline Inc. Class A common stockCDC1.6x—26.2%6.0%$35.96
RMDResMed Inc.CCB5.9x12.1%61.1%33.4%$238.97
DXCMDexCom, Inc.CBB6.5x19.3%64.3%22.9%$86.04
WSTWest Pharmaceutical Services, Inc.DCA8.5x7.4%36.8%20.4%$384.02
SOLVSolventum CorporationCCB1.8x—54.8%23.9%$85.81
BAXBaxter International Inc.BDB1.1x-0.8%30.7%-2.3%$25.28

About Brainsway Ltd. American Depositary Shares

BrainsWay Ltd develops Deep Transcranial Magnetic Stimulation (Deep TMS), a noninvasive neurostimulation platform for treating mental health and neurological disorders. The company currently generates revenue through lease and sale of Deep TMS systems for FDA-approved indications including major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Additional clinical trials are underway to expand the platform's therapeutic applications across psychiatric, neurological, and addiction disorders.